Clinical efficacy analysis of Osimertinib treatment for a patient with leptomeningeal metastasis of EGFR+ non-small cell lung cancer without the T790M mutation (vol 8, pg 525, 2019)-MedSci.cn

Clinical efficacy analysis of Osimertinib treatment for a patient with leptomeningeal metastasis of EGFR+ non-small cell lung cancer without the T790M mutation (vol 8, pg 525, 2019)

Hu, XY; Chen, WJ; Li, XQ; Zhao, CC; Zhang, CJ; Xiong, FX; Wu, HY

Wu, HY (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Med Oncol, Hefei 230031, Peoples R China.